Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (301-310 of 662) with videos related to

Pageof 67
Sort By:
Leukemia Research|May 3, 2005
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experienceAlexandra Böhm, Maria Piribauer, Friedrich Wimazal, et al.
Genes, Chromosomes & Cancer|January 9, 2008
Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission durationKatja Haas, Michael Kundi, Wolfgang R Sperr, et al.
Leukemia & Lymphoma|September 14, 2004
Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantationHermine Agis, Christine Mannhalter, Wolfgang R Sperr, et al.
Leukemia & Lymphoma|December 29, 2004
Mastocytosis: pathology, genetics, and current options for therapyPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Disruption of allergenic activity of the major grass pollen allergen Phl p 2 by reassembly as a mosaic proteinNadine Mothes-Luksch, Sabine Stumvoll, Birgit Linhart, et al.
Breast Cancer Research and Treatment|November 4, 2010
The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cellsCaroline Brünner-Kubath, Waheed Shabbir, Victoria Saferding, et al.
Stem Cells and Development|July 26, 2013
Endogenous erythroid colony formation in chronic myeloid leukemia: a recurrent finding associated with persistent minimal residual disease under imatinibElisa Einwallner, Eva Jaeger, Gerlinde Mitterbauer-Hohendanner, et al.
Journal of Cutaneous Pathology|June 21, 2021
Case report of a clinically indolent but morphologically high-grade cutaneous mast cell tumor in an adult: Atypical cutaneous mastocytoma or mast cell sarcoma?Claire L W Wardle, J Marja Oldhoff, Arjan Diepstra, et al.
Cancer Research|April 4, 2002
The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanomaEdgar Selzer, Volker Wacheck, Trevor Lucas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patientsAbdolreza Rezaie-Majd, Gerald W Prager, Robert A Bucek, et al.
Pageof 67

Showing results (301-310 of 662) with videos related to

Sort By:
Pageof 67
Leukemia Research|May 3, 2005
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experienceAlexandra Böhm, Maria Piribauer, Friedrich Wimazal, et al.
Genes, Chromosomes & Cancer|January 9, 2008
Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission durationKatja Haas, Michael Kundi, Wolfgang R Sperr, et al.
Leukemia & Lymphoma|September 14, 2004
Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantationHermine Agis, Christine Mannhalter, Wolfgang R Sperr, et al.
Leukemia & Lymphoma|December 29, 2004
Mastocytosis: pathology, genetics, and current options for therapyPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Disruption of allergenic activity of the major grass pollen allergen Phl p 2 by reassembly as a mosaic proteinNadine Mothes-Luksch, Sabine Stumvoll, Birgit Linhart, et al.
Breast Cancer Research and Treatment|November 4, 2010
The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cellsCaroline Brünner-Kubath, Waheed Shabbir, Victoria Saferding, et al.
Stem Cells and Development|July 26, 2013
Endogenous erythroid colony formation in chronic myeloid leukemia: a recurrent finding associated with persistent minimal residual disease under imatinibElisa Einwallner, Eva Jaeger, Gerlinde Mitterbauer-Hohendanner, et al.
Journal of Cutaneous Pathology|June 21, 2021
Case report of a clinically indolent but morphologically high-grade cutaneous mast cell tumor in an adult: Atypical cutaneous mastocytoma or mast cell sarcoma?Claire L W Wardle, J Marja Oldhoff, Arjan Diepstra, et al.
Cancer Research|April 4, 2002
The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanomaEdgar Selzer, Volker Wacheck, Trevor Lucas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patientsAbdolreza Rezaie-Majd, Gerald W Prager, Robert A Bucek, et al.
Pageof 67